324 related articles for article (PubMed ID: 16204296)
1. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
[TBL] [Abstract][Full Text] [Related]
2. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal dialysis fluid-induced changes of the peritoneal membrane are reversible after peritoneal rest in rats.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Nephrol Dial Transplant; 2005 Jan; 20(1):189-93. PubMed ID: 15572385
[TBL] [Abstract][Full Text] [Related]
4. Better preservation of the peritoneum in rats exposed to amino acid-based peritoneal dialysis fluid.
Zareie M; van Lambalgen AA; ter Wee PM; Hekking LH; Keuning ED; Schadee-Eestermans IL; Faict D; Degréve B; Tangelder GJ; Beelen RH; van den Born J
Perit Dial Int; 2005; 25(1):58-67. PubMed ID: 15770927
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis fluid bioincompatibility and new vessel formation promote leukocyte-endothelium interactions in a chronic rat model for peritoneal dialysis.
Schilte MN; Fabbrini P; Wee PM; Keuning ED; Zareie M; Tangelder GJ; Van Lambalgen AA; Beelen RH; Van Den Born J
Microcirculation; 2010 May; 17(4):271-80. PubMed ID: 20536740
[TBL] [Abstract][Full Text] [Related]
6. Immunopathological changes in a uraemic rat model for peritoneal dialysis.
Zareie M; De Vriese AS; Hekking LH; ter Wee PM; Schalkwijk CG; Driesprong BA; Schadee-Eestermans IL; Beelen RH; Lameire N; van den Born J
Nephrol Dial Transplant; 2005 Jul; 20(7):1350-61. PubMed ID: 15840671
[TBL] [Abstract][Full Text] [Related]
7. Novel role for mast cells in omental tissue remodeling and cell recruitment in experimental peritoneal dialysis.
Zareie M; Fabbrini P; Hekking LH; Keuning ED; Ter Wee PM; Beelen RH; van den Born J
J Am Soc Nephrol; 2006 Dec; 17(12):3447-57. PubMed ID: 17065241
[TBL] [Abstract][Full Text] [Related]
8. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane.
Mortier S; Faict D; Schalkwijk CG; Lameire NH; De Vriese AS
Kidney Int; 2004 Sep; 66(3):1257-65. PubMed ID: 15327425
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib treatment reduces peritoneal fibrosis and angiogenesis and prevents ultrafiltration failure in experimental peritoneal dialysis.
Fabbrini P; Schilte MN; Zareie M; ter Wee PM; Keuning ED; Beelen RH; van den Born J
Nephrol Dial Transplant; 2009 Dec; 24(12):3669-76. PubMed ID: 19666665
[TBL] [Abstract][Full Text] [Related]
10. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
12. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
13. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal dialysis solution attenuates microvascular leukocyte adhesion induced by nitric oxide synthesis inhibition.
White R; Ram S
Adv Perit Dial; 1996; 12():53-6. PubMed ID: 8865873
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
16. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
[TBL] [Abstract][Full Text] [Related]
17. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
18. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
Günal AI; Celiker H; Ustundag B; Akpolat N; Dogukan A; Akcicek F
J Nephrol; 2003; 16(2):225-30. PubMed ID: 12768069
[TBL] [Abstract][Full Text] [Related]
19. Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters.
Zareie M; Keuning ED; ter Wee PM; Beelen RH; van den Born J
Adv Perit Dial; 2004; 20():150-4. PubMed ID: 15384817
[TBL] [Abstract][Full Text] [Related]
20. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
